Opportunity Information: Apply for PAR 19 352

The NIH grant opportunity titled "Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)" (Funding Opportunity Number PAR-19-352) supports research that tests interventions aimed at helping caregivers of adult cancer patients. The core idea is that cancer caregiving is not just a family issue but a major part of the patient care ecosystem, and caregiver strain, lack of training, or poor support can spill over into the patient experience, affecting symptoms, adherence, crisis events, and how often patients end up in high-cost settings like emergency departments or inpatient units. This FOA is looking for well-designed intervention studies that equip caregivers with practical care skills and emotional or behavioral coping tools so they can manage caregiving demands more effectively over time.

The interventions envisioned under this announcement focus on three linked outcome areas. First, projects should aim to optimize patient health care utilization, meaning the intervention should plausibly reduce avoidable or inefficient use of health services while supporting appropriate, timely care. That can include outcomes like fewer preventable emergency visits, fewer unplanned hospitalizations or readmissions, improved use of outpatient or supportive services, smoother transitions of care, or better coordination that prevents crises. Second, interventions are expected to improve caregiver well-being, which can include reducing stress, depression, anxiety, burden, sleep disruption, or social isolation, and improving caregiver confidence, preparedness, self-efficacy, and quality of life. Third, projects should aim to improve patient outcomes, both physical (for example, symptom control, functional status, treatment tolerance, adherence to care plans) and psychosocial (such as distress, mood, coping, communication, or overall quality of life). The FOA ties these together by treating caregiver support as a pathway to better outcomes for both the patient and the health system.

This is an R01 mechanism, which typically supports substantial, multi-year research projects that can rigorously test an intervention and generate strong evidence. The label "Clinical Trial Optional" indicates that applicants may propose studies that do or do not meet NIH's definition of a clinical trial; in practice, many caregiver intervention studies do involve randomization or other designs that qualify as clinical trials, but the announcement does not require it. What matters is that the application proposes intervention research with clear caregiver-focused content (such as care training and coping skills development) and a strong plan to measure the downstream effects on utilization, caregiver outcomes, and patient outcomes.

Eligibility is broad and includes many U.S.-based organization types: state, county, and local governments; special district governments; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it places firm limits on foreign involvement: non-U.S. entities and foreign institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed. In short, the work needs to be led and carried out within eligible U.S.-based organizational structures without foreign components.

Administratively, this is a discretionary grant opportunity from the National Institutes of Health. It sits within health and education-related funding activity categories and is associated with CFDA numbers 93.395 and 93.399. The FOA was created on 2019-08-29, and the listed original closing date is 2022-09-07. The source data does not specify an award ceiling, the expected number of awards, or other budget summary details, so applicants would typically look to the full FOA text and NIH policy for budget formatting expectations under the R01 mechanism.

Overall, PAR-19-352 is designed for investigators and organizations that want to test practical, scalable ways to strengthen the caregiver role in adult cancer care. Competitive projects will generally be those that make a clear case for why the caregiver intervention should change patient utilization patterns and patient outcomes, specify measurable endpoints in all three domains (utilization, caregiver well-being, and patient physical/psychosocial health), and use a rigorous design appropriate for an R01-level evaluation.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395, 93.399.
  • This funding opportunity was created on 2019-08-29.
  • Applicants must submit their applications by 2022-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 19 352

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Caregivers

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed)

Previous opportunity: Assessing the factors affecting forest condition along APPA

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 19 352

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 19 352) also looked into and applied for these:

Funding Opportunity
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) Apply for PAR 19 359

Funding Number: PAR 19 359
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $50,000
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) Apply for PAR 19 361

Funding Number: PAR 19 361
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PAR 19 363

Funding Number: PAR 19 363
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) Apply for RFA CA 19 049

Funding Number: RFA CA 19 049
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) Apply for RFA CA 19 050

Funding Number: RFA CA 19 050
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) Apply for RFA CA 19 051

Funding Number: RFA CA 19 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) Apply for RFA CA 19 052

Funding Number: RFA CA 19 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) Apply for RFA CA 19 053

Funding Number: RFA CA 19 053
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Apply for PAR 19 368

Funding Number: PAR 19 368
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) Apply for RFA HL 20 006

Funding Number: RFA HL 20 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required) Apply for RFA CA 19 056

Funding Number: RFA CA 19 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowed) Apply for RFA DA 20 010

Funding Number: RFA DA 20 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) Apply for RFA CA 19 064

Funding Number: RFA CA 19 064
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional) Apply for PAR 19 377

Funding Number: PAR 19 377
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed) Apply for RFA CA 19 042

Funding Number: RFA CA 19 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional) Apply for RFA DA 20 014

Funding Number: RFA DA 20 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Apply for RFA DA 20 026

Funding Number: RFA DA 20 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Patient Activation for Self-Management of Chronic Conditions (R01 Clinical Trial Optional) Apply for PAR 19 381

Funding Number: PAR 19 381
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Patient Activation for Self-Management of Chronic Conditions (R21 Clinical Trial Optional) Apply for PAR 19 382

Funding Number: PAR 19 382
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) Apply for RFA CA 19 054

Funding Number: RFA CA 19 054
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,330,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 352", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: